As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Indian enterprises are navigating challenges posed by the Goods and Services Tax. The inverted duty scenario is particularly affecting FMCG...

India's recent free trade agreements are set to boost the domestic pharma and healthcare industries. Commerce Minister Piyush Goyal highlig...

Markets are range-bound due to weak earnings, global trade tensions, and a lack of sectoral leadership. The India-UK FTA offers opportuniti...

Despite global economic uncertainties, India's exports reached a record USD 825 billion in 2024-25, and are projected to surpass this figur...

The US order to lower prescription drug prices is unlikely to impact Indian generic drugmakers, as they already operate on low margins, exp...

As Trump’s April 2 tariff decision looms, Indian markets brace for potential fallout. Mild tariffs could boost export-driven sectors like p...

India's economic prospects are influenced by global policies like China + 1 strategy, India-UK FTA and USA's trade policies. These policies...

"The recently announced India-Middle East-Europe Economic Corridor (IMEC) is a strategic and economic game-changer for India and others," F...

India achieved an all-time high annual merchandise export of $422 billion in FY22. The Netherlands has displaced China from the third spot ...

India's exports contracted by 12.2 per cent to USD 34.48 billion in December 2022 due to the global demand slowdown, and the trade deficit ...

Commerce Secretary Anup Wadhawan said the country's merchandise exports were impacted on account of the COVID pandemic.

While India has managed to capture the services outsourcing wave to become quite the back office of the world, the ability to expand the ma...

Domestic industry and exporters have raised concerns over these pacts saying they have benefited India's trading partners more.

The India-Australia comprehensive trade pact will be the next milestone in their bilateral relationship, which got a boost from Prime Minis...

Drugmakers are worried that the India-EU FTA, which is in the works, may contain a provision that could imperil local industry.

A section of India’s generic drug industry has claimed that its ability to export generic drugs to over a dozen countries with which the US...